ReviewDegenerative neurological and neuromuscular disease2017

Advances in the treatment of relapsing-remitting multiple sclerosis: the role of pegylated interferon β-1a.

Kendra L Furber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.